90 related articles for article (PubMed ID: 11189486)
1. [Study on the relationship between DNA topoisomerase II activity and multidrug resistance in leukemic cells].
Zheng W; Xie Z; Tang G
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):470-2. PubMed ID: 11189486
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between abnormal MDR gene expression and chemotherapy response in lymphoid malignancies].
Xu YC; Lin YM; Zhang FC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):353-6. PubMed ID: 17044999
[TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering ER; Kaspers GJ; Veerman AJ
Leukemia; 1995 Oct; 9(10):1653-60. PubMed ID: 7564505
[TBL] [Abstract][Full Text] [Related]
5. [Detection and analysis of multidrug resistance in 100 cases of acute leukemia].
Luan FJ; Yang CZ; Shao XF
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):360-3. PubMed ID: 7895588
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of P-gp, mdr1, MRP and Topo II in acute leukemia patients and their correlation with prognosis].
Shanghai Cooperative Group Of Leukemias
Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):90-3. PubMed ID: 11877057
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene (mrp) and mdr-1/p170 expression in acute leukemia].
Zhao Y; Yu L; Lou F; Wang Q; Pu J; Zhou Q
Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):760-3. PubMed ID: 11798719
[TBL] [Abstract][Full Text] [Related]
8. Expression of DNA topoisomerase II alpha and multidrug resistance p-glycoprotein in acute leukemia.
Chiu CF; Chow KC; Lin FM; Lin CK; Liu SM; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):184-90. PubMed ID: 9439046
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
11. [The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180's tumor cell induced by chemotherapy in the mice with acquired multi-drug resistance].
Li GH; Liu MX; Sun FJ; Wang N; Yin GP; Li XJ; Li WF
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1280-2. PubMed ID: 16245910
[TBL] [Abstract][Full Text] [Related]
12. Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
Wang YH; Takanashi M; Tsuji K; Tanaka N; Shiseki M; Mori N; Motoji T
Leuk Res; 2009 Jul; 33(7):902-7. PubMed ID: 19185918
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
Chen M; Beck WT
Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
[TBL] [Abstract][Full Text] [Related]
14. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between cyclin B1 and multidrug resistance in adult patients with acute leukemia].
Ma WD; Xu SR; Guo XN; Gao XL; Ma J; Qiao SK
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):169-72. PubMed ID: 12816698
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
17. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
18. [The correlation of cyclin A gene expression with drug resistance in adult acute leukemia patients].
Ma J; Xu S; Lai Y; Lu Y
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):243-6. PubMed ID: 12133445
[TBL] [Abstract][Full Text] [Related]
19. Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL.
Zhou R; Vitols S; Gruber A; Liliemark J; Wang Y; Liliemark E
Br J Haematol; 1999 May; 105(2):420-7. PubMed ID: 10233413
[TBL] [Abstract][Full Text] [Related]
20. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
